Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Coachella Valley Behavioral Health Hosts Ceremony to Celebrate Grand Opening: https://mms.businesswire.com/media/20231214490244/en/1971221/5/ACHCCoachella_Valley_photo.jpg
Coachella Valley Behavioral Health Hosts Ceremony to Celebrate Grand Opening


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the opening of its newest acute care hospital, Coachella Valley Behavioral Health, located at 81555 JFK Court in Indio, California. A

Why Medtronic Stock Topped the Market on Thursday: https://g.foolcdn.com/editorial/images/758350/patient-and-physician-smiling-during-a-visit.jpg
Why Medtronic Stock Topped the Market on Thursday

Prominent medical-device maker Medtronic (NYSE: MDT) was a hit on the stock exchange Thursday. The company's share price rose by nearly 2% following regulatory approval of an important new product

Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations: https://mms.businesswire.com/media/20231214650148/en/1971044/5/30.jpg
Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations


Agilent Technologies Inc. (NYSE: A) today announced the company’s manufacturing facility in Waldbronn, Germany, has been named a Global Lighthouse by the World Economic Forum (WEF) for innovations

CenterWell Home Health collects 289,000 meals for needy Americans: https://mms.businesswire.com/media/20231214133178/en/1969536/5/IMG_0004_Grand_Junction.jpg
CenterWell Home Health collects 289,000 meals for needy Americans


CenterWell Home Health, one of America’s largest providers of home health, has supplied more than a quarter-million meals in its latest drive to feed people in need in the communities it serves

3 Stocks to Buy Before 2024 That Can Set You Up For Life: https://g.foolcdn.com/editorial/images/757806/a-couple-smiling-and-talking-with-an-advisor.jpg
3 Stocks to Buy Before 2024 That Can Set You Up For Life

You shouldn't have to keep a close eye on your investments. If you find solid stocks to buy, you can leave them in your portfolio and simply wait for their operations to grow and become larger over

3 Stocks to Buy Before 2024 That Can Set You Up For Life: https://g.foolcdn.com/editorial/images/757806/a-couple-smiling-and-talking-with-an-advisor.jpg
3 Stocks to Buy Before 2024 That Can Set You Up For Life

You shouldn't have to keep a close eye on your investments. If you find solid stocks to buy, you can leave them in your portfolio and simply wait for their operations to grow and become larger over

3 Stocks to Buy Before 2024 That Can Set You Up For Life: https://g.foolcdn.com/editorial/images/757806/a-couple-smiling-and-talking-with-an-advisor.jpg
3 Stocks to Buy Before 2024 That Can Set You Up For Life

You shouldn't have to keep a close eye on your investments. If you find solid stocks to buy, you can leave them in your portfolio and simply wait for their operations to grow and become larger over

Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?: https://g.foolcdn.com/editorial/images/757807/a-couple-counting-money.jpg
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?

When dividend stocks crash in value, that sends their yields up in the opposite direction. But there can be danger for investors who load up on a stock just because its yield is high.

Before buying

Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?: https://g.foolcdn.com/editorial/images/757807/a-couple-counting-money.jpg
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?

When dividend stocks crash in value, that sends their yields up in the opposite direction. But there can be danger for investors who load up on a stock just because its yield is high.

Before buying

Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?: https://g.foolcdn.com/editorial/images/758152/device-investor-getty.jpg
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?

Pfizer (NYSE: PFE) was a top performer when the U.S. government was shoveling COVID-related revenue in its direction. Unfortunately, the past year hasn't been nearly as kind. The former high-flying

Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?: https://g.foolcdn.com/editorial/images/758152/device-investor-getty.jpg
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?

Pfizer (NYSE: PFE) was a top performer when the U.S. government was shoveling COVID-related revenue in its direction. Unfortunately, the past year hasn't been nearly as kind. The former high-flying

EQS-News: Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg
EQS-News: Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases
EQS-News: Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
EQS-Adhoc: Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process
Why Vertex Stock Is Soaring Today: https://g.foolcdn.com/editorial/images/758217/break-through-ceiling.jpg
Why Vertex Stock Is Soaring Today

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are up by more than 11% headed into the latter half of Wednesday's trading session, catapulted higher by the promising results achieved in a mid-stage

Why Vertex Stock Is Soaring Today: https://g.foolcdn.com/editorial/images/758217/break-through-ceiling.jpg
Why Vertex Stock Is Soaring Today

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are up by more than 11% headed into the latter half of Wednesday's trading session, catapulted higher by the promising results achieved in a mid-stage

Why Vertex Stock Is Soaring Today: https://g.foolcdn.com/editorial/images/758217/break-through-ceiling.jpg
Why Vertex Stock Is Soaring Today

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are up by more than 11% headed into the latter half of Wednesday's trading session, catapulted higher by the promising results achieved in a mid-stage

Why Pfizer Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/758185/stock-chart-trending-down-with-man.jpg
Why Pfizer Stock Is Sinking Today

Shares of Pfizer (NYSE: PFE) were sinking 8.3% lower as of 11:25 a.m. ET on Wednesday. The sharp sell-off came after the drugmaker provided its guidance for full-year 2024.

Pfizer expects 2024

Why Pfizer Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/758185/stock-chart-trending-down-with-man.jpg
Why Pfizer Stock Is Sinking Today

Shares of Pfizer (NYSE: PFE) were sinking 8.3% lower as of 11:25 a.m. ET on Wednesday. The sharp sell-off came after the drugmaker provided its guidance for full-year 2024.

Pfizer expects 2024

1 Biotech Stock That Could Be the Next Amgen: https://g.foolcdn.com/editorial/images/758114/innovation.jpg
1 Biotech Stock That Could Be the Next Amgen

The human genome project, which was completed in 2003, marked a milestone for biotechnology. It opened the door for the creation of hundreds of medicines based on biology, which have improved the

1 Biotech Stock That Could Be the Next Amgen: https://g.foolcdn.com/editorial/images/758114/innovation.jpg
1 Biotech Stock That Could Be the Next Amgen

The human genome project, which was completed in 2003, marked a milestone for biotechnology. It opened the door for the creation of hundreds of medicines based on biology, which have improved the